vs
Side-by-side financial comparison of MACROGENICS INC (MGNX) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $41.2M, roughly 1.7× MACROGENICS INC). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs -1.8%). MACROGENICS INC produced more free cash flow last quarter ($42.8M vs $33.5M). Over the past eight quarters, MACROGENICS INC's revenue compounded faster (112.8% CAGR vs -4.7%).
MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
MGNX vs RMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.2M | $71.1M |
| Net Profit | — | $1.4M |
| Gross Margin | — | — |
| Operating Margin | -29.3% | 13.1% |
| Net Margin | — | 2.0% |
| Revenue YoY | 113.0% | -1.8% |
| Net Profit YoY | — | -75.2% |
| EPS (diluted) | $-0.23 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.2M | $71.1M | ||
| Q3 25 | $72.8M | $73.2M | ||
| Q2 25 | $22.2M | $72.8M | ||
| Q1 25 | $13.2M | $74.5M | ||
| Q4 24 | $19.4M | $72.5M | ||
| Q3 24 | $110.7M | $78.5M | ||
| Q2 24 | $10.8M | $78.5M | ||
| Q1 24 | $9.1M | $78.3M |
| Q4 25 | — | $1.4M | ||
| Q3 25 | $16.8M | $4.0M | ||
| Q2 25 | $-36.3M | $4.7M | ||
| Q1 25 | $-41.0M | $-2.0M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $56.3M | $966.0K | ||
| Q2 24 | $-55.7M | $3.7M | ||
| Q1 24 | $-52.2M | $-3.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 98.8% | — | ||
| Q3 24 | 99.8% | — | ||
| Q2 24 | 98.4% | — | ||
| Q1 24 | 97.0% | — |
| Q4 25 | -29.3% | 13.1% | ||
| Q3 25 | 25.6% | 25.0% | ||
| Q2 25 | -165.3% | 19.3% | ||
| Q1 25 | -323.1% | 7.2% | ||
| Q4 24 | -273.0% | 5.9% | ||
| Q3 24 | 48.9% | 19.4% | ||
| Q2 24 | -538.9% | 20.6% | ||
| Q1 24 | -590.4% | 5.8% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | 23.1% | 5.4% | ||
| Q2 25 | -163.0% | 6.4% | ||
| Q1 25 | -311.1% | -2.6% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 50.9% | 1.2% | ||
| Q2 24 | -515.6% | 4.7% | ||
| Q1 24 | -573.3% | -4.3% |
| Q4 25 | $-0.23 | — | ||
| Q3 25 | $0.27 | — | ||
| Q2 25 | $-0.57 | — | ||
| Q1 25 | $-0.65 | — | ||
| Q4 24 | $-0.24 | — | ||
| Q3 24 | $0.90 | — | ||
| Q2 24 | $-0.89 | — | ||
| Q1 24 | $-0.84 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.2M | $118.7M |
| Total DebtLower is stronger | — | $432.2M |
| Stockholders' EquityBook value | $55.6M | $452.4M |
| Total Assets | $256.8M | $582.5M |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.2M | $118.7M | ||
| Q3 25 | $80.1M | $107.5M | ||
| Q2 25 | $130.7M | $94.3M | ||
| Q1 25 | $145.6M | $89.1M | ||
| Q4 24 | $182.8M | $96.6M | ||
| Q3 24 | $179.6M | $83.8M | ||
| Q2 24 | $83.9M | $66.1M | ||
| Q1 24 | $80.4M | $82.1M |
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
| Q4 25 | $55.6M | $452.4M | ||
| Q3 25 | $67.0M | $448.1M | ||
| Q2 25 | $46.6M | $442.4M | ||
| Q1 25 | $79.1M | $433.5M | ||
| Q4 24 | $116.1M | $429.5M | ||
| Q3 24 | $120.1M | $423.1M | ||
| Q2 24 | $57.8M | $418.4M | ||
| Q1 24 | $106.2M | $412.0M |
| Q4 25 | $256.8M | $582.5M | ||
| Q3 25 | $270.8M | $582.2M | ||
| Q2 25 | $245.4M | $574.8M | ||
| Q1 25 | $224.6M | $571.4M | ||
| Q4 24 | $261.7M | $581.6M | ||
| Q3 24 | $264.5M | $578.6M | ||
| Q2 24 | $201.1M | $571.4M | ||
| Q1 24 | $248.3M | $566.7M |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.0M | $40.9M |
| Free Cash FlowOCF − Capex | $42.8M | $33.5M |
| FCF MarginFCF / Revenue | 103.8% | 47.1% |
| Capex IntensityCapex / Revenue | 0.6% | 10.4% |
| Cash ConversionOCF / Net Profit | — | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-83.0M | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.0M | $40.9M | ||
| Q3 25 | $-30.2M | $17.7M | ||
| Q2 25 | $-47.0M | $4.6M | ||
| Q1 25 | $-46.9M | $5.7M | ||
| Q4 24 | $-38.4M | $59.7M | ||
| Q3 24 | $60.2M | $17.6M | ||
| Q2 24 | $-44.5M | $15.9M | ||
| Q1 24 | $-45.6M | $9.4M |
| Q4 25 | $42.8M | $33.5M | ||
| Q3 25 | $-30.6M | $16.4M | ||
| Q2 25 | $-47.7M | $2.9M | ||
| Q1 25 | $-47.4M | $4.0M | ||
| Q4 24 | $-39.0M | $53.0M | ||
| Q3 24 | $59.6M | $16.3M | ||
| Q2 24 | $-45.5M | $14.0M | ||
| Q1 24 | $-47.1M | $6.8M |
| Q4 25 | 103.8% | 47.1% | ||
| Q3 25 | -42.0% | 22.4% | ||
| Q2 25 | -214.5% | 4.0% | ||
| Q1 25 | -359.5% | 5.3% | ||
| Q4 24 | -201.7% | 73.2% | ||
| Q3 24 | 53.8% | 20.8% | ||
| Q2 24 | -421.6% | 17.8% | ||
| Q1 24 | -517.4% | 8.6% |
| Q4 25 | 0.6% | 10.4% | ||
| Q3 25 | 0.6% | 1.8% | ||
| Q2 25 | 3.2% | 2.2% | ||
| Q1 25 | 4.0% | 2.3% | ||
| Q4 24 | 3.2% | 9.1% | ||
| Q3 24 | 0.5% | 1.7% | ||
| Q2 24 | 9.6% | 2.4% | ||
| Q1 24 | 16.0% | 3.3% |
| Q4 25 | — | 28.39× | ||
| Q3 25 | -1.79× | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | 1.07× | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
